Gain a competitive advantage for your study in the ever-evolving landscape of hematology and oncology drug and biologic clinical development. With our unique approach to clinical research, we have earned a reputation for taking on some of the most complex and challenging cancer research studies. We help our clients:
Develop successful strategies for even the most novel therapies
Plan and conduct effective studies
Compete successfully for high-performing global sites
Expedite study start-up and recruitment
Navigate the global regulatory landscape to expedite approvals
Medpace has the medical leadership, hematology and oncology trained staff, global trial experience, and site relationships to make your study a success.
Experienced Hematology and Oncology CRO
Medpace has deep and broad experience in the hematology and oncology space, giving you confidence that we can successfully complete your study. We have conducted research in a full range of solid tumor and hematologic indications and therapies from classic multi-cytotoxic agents to cutting-edge and targeted therapies. Whether your study is a small, focused trial or a large, global study, Medpace has the knowledge and expertise to give you a competitive advantage including:
Oncology medical experts who provide strategic, educational and practical leadership
Comprehensive hematology/oncology training program for all operational staff
Long-term relationships with successful, experienced sites and preferred CRO status with key Phase I oncology centers
Important Cookie Information – This message will only appear once.
Medpace websites use cookies. By continuing to browse the site you are agreeing to our use of cookies.
For more details about cookies and their use, please see our Privacy Policy.
